Antares Pharma Inc (NASDAQ:ATRS)

2.13
Delayed Data
As of Jul 02
 -0.01 / -0.47%
Today’s Change
1.82
Today|||52-Week Range
3.04
-17.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues6.3M6.6M8.4M8.3M
 
 
 
 
 
Cost of Goods Sold1.9M2.1M5.1M3.3M
 
 
 
 
 
Depreciation And Amortization279.0K369.4K351.1K378.6K
 
 
 
 
 
 
Operating ExpensesGross Income4.2M4.1M3.0M4.7M
 
 
 
 
 
General Expenses12.7M10.8M13.0M11.4M
 
 
 
 
 
Research And Development3.9M4.4M5.7M4.4M
 
 
 
 
 
Total Operating Expenses14.8M13.3M18.4M15.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.5M-6.8M-10.0M-6.7M
 
 
 
 
 
Extraordinary Charge-580.0K-400.0K--0.00
 
 
 
Other Expenses-6.6K-12.8K-8.0K-45.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.1M-7.2M-10.0M-6.8M
 
 
 
 
 
Income Taxes0.000.00-25.0K0.00
 
 
Net Income-9.1M-7.2M-10.1M-6.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS130.1M130.8M131.7M131.7M
 
 
 
 
 
Shares To Calculate EPS Diluted130.1M130.8M131.7M131.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.05-$0.08-$0.05
 
 
 
 
 
EPS Diluted-$0.07-$0.05-$0.08-$0.05
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account